tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Sanofi SA (SNY)
:SNY
US Market
SNY
Sanofi
RESEARCH TOOLSreports
Advertisement

Sanofi (SNY) Stock News & Sentiment

Compare
2,146 Followers
Sanofi Advances with Dupixent and Teizeild Approvals in November 2025
Premium
Company Announcements
Sanofi Advances with Dupixent and Teizeild Approvals in November 2025
6d ago
6K
SNY
Sanofi Issues $3 Billion in Notes to Bolster Financial Strategy
Premium
Company Announcements
Sanofi Issues $3 Billion in Notes to Bolster Financial Strategy
21d ago
6K
SNY
Sanofi’s Efdoralprin Alfa Achieves Key Milestones in AATD Emphysema Study
Premium
Company Announcements
Sanofi’s Efdoralprin Alfa Achieves Key Milestones in AATD Emphysema Study
24d ago
6K
SNY
Sanofi Successfully Prices $3 Billion Bond Issue
Premium
Company Announcements
Sanofi Successfully Prices $3 Billion Bond Issue
27d ago
6K
SNY
Sanofi’s Rilzabrutinib Study: A New Chapter in ITP Treatment
Premium
Company Announcements
Sanofi’s Rilzabrutinib Study: A New Chapter in ITP Treatment
28d ago
SNY
Regeneron and Sanofi Launch New Study on Dupilumab for Children’s Growth and Bone Health
Premium
Company Announcements
Regeneron and Sanofi Launch New Study on Dupilumab for Children’s Growth and Bone Health
28d ago
SNY
REGN
Sanofi’s New Phase 2 Study on Brivekimig for Hidradenitis Suppurativa: What Investors Need to Know
Premium
Company Announcements
Sanofi’s New Phase 2 Study on Brivekimig for Hidradenitis Suppurativa: What Investors Need to Know
28d ago
SNY
More SNY News >

SNY News on the Web

Biotech Reawakens: Policy Clarity, Breakthrough Data and a Surge in M&A
Live Wire
Neutral
REGN Gets EC Nod for Libtayo Label Expansion, FDA Clears Monthly Eylea HD
Zacks
Neutral
Sanofi Advances with Dupixent and Teizeild Approvals in November 2025
TipRanks News
Neutral
Sanofi’s $470M Vigil Neuroscience Deal Underscores 2025’s Record Year for Biotech Innovation
Market Chameleon
Neutral
Is Sanofi (SNY) Overvalued?
AAII
Neutral
Is Sanofi (SNY) Overvalued?
AAII
Neutral
Is Sanofi (SNY) Overvalued?
AAII
Neutral
The Zacks Analyst Blog Accenture, Sanofi and Dell
Zacks
Neutral

News Score - Last 7 Days

Neutral
SNY
Sector Average
Media Buzz
This Week4 articles
Weekly Average6.5 articles
News Sentiment
This Week50%
Sector Average58%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SNY’s Media Buzz Sentiment?
4 articles about SNY were published this week. In an average week, 6.5 articles are published.
    What is SNY’s weekly average amount of articles?
    In an average week, 6.5 articles about SNY are published.
      What is SNY’s News Sentiment?
      50% of articles about SNY were positive this week, compared to its sector average of 58%.
        Healthcare Stocks that are Trending in the News
        MDTMedtronic
        NOTVInotiv
        AGIOAgios Pharma
        PAHCPhibro Animal Health
        LLYEli Lilly & Co
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing